SUMMARY
SUMMARY
The application of phenol to the femoral veins of anesthetized dogs resulted in an occluding thrombus in 24 of 25 veins at 1 week. Serial venography and eventual histology showed that these veins remained occluded over a 5-week observation period, the thrombi undergoing organization. Therapeutic defibrination was achieved with administration of an enzyme from venom of the pit viper (Arvin). Arvin, administered for 1 week immediately following phenol application and before thrombus formation had occurred, prevented thrombosis in all 10 such veins, and serial venography for a further 4 weeks showed that the veins remained patent. Administration of Arvin was begun 24 hours postoperatively, when venography had demonstrated an occluding thrombus and failed to clear any of 11 veins after 3 weeks of treatment.
Intravenous administration of heparin, 10 ,000 units, at 6, 6 , and 12-hour intervals in a 24-hour period, was begun immediately after phenol application and continued for 1 week; 10 hours, the timing of injections being dependent upon the plasma fibrinogen concentration. The aim of therapy was to maintain plasma fibrinogeni, estimated as thrombin-clottable protein,') below 50 mg/ 100 ml. The duration of therapy was 1 veek for prophylactic treatment an-d 3 weeks for treatment of established thrombosis.
Heparin Therapy
Heparin was administered by intermittent injection through an indwelling catheter introduced via the jugular vein to the central circulation. Hepaiin in dosages of 10,000 tunits was given either three or four times in a 24-hour period. In one scheduile, heparin was given-at 7 a.m., 1 p.m., anid 7 p.m., and in the other schedule, heparin was given every six hours.
Heparin therapy was continued for 1 week and was monitored by measurements of whole blood coagulation time and assay of plasma heparin concentration." Coagulation times and plasma heparin concentrations were determined 6 hours after the injection of 10,000 units of heparini; that is, immediately prior to the next dose of heparin. Coagulation times were prolonged to two to five times the normal value and plasma heparin concentrations were usually 0.5 to 2.0 units/ml. Thus, the animals receiving heparini by the 6-hourly schedule had a high level of anticoagulation at all times. 
Results

Control Experiments
Venograms performed immediately after closure of the groin wounds showed the femoral veins to be patent, but occlusion with thrombus was observed on subsequent examinations. The animals suffered no outward ill effects from the femoral vein thrombosis; that is, there was no edema or increase in limb width. Collateral pathways were opened up A further eight dogs were given heparin in a dose of 10,000 units every 6 hours. The more frequent injections (the 6-hourly schedule) were associated with a high incidence of bleeding, which proved fatal in four of the eight dogs. Of the eight veins available for study at the end of 1 week of heparin therapy, four were occluded by thrombus (table 3). The incidence of thrombosis was significantly less than in animals given heparin three times a day or in the control animals (P < 0.01 ), but Circulation, Volume XLII, October 1970 was greater than that seen in the animals treated with Arvin (P < 0.05).
Thrombi which occurred during heparin therapy showed some differences from those in control animals when examined histologically 1 week after the application of phenol. Organization had not commenced at 1 week in thrombi from the heparin-treated dogs, whereas it was always present in thrombi obtained from control animals. The appearances suggested that the thrombi in the treated animals were more recent than those in the controls.
Treatment of Established Thrombosis with Arvin
Arvin treatment was commenced in nine dogs 24 hours after operation when venography had shown that 13 of 18 veins subjected to phenol application were obstructed. Thus, the thrombus in these cases was less than 24 hours old. Hemorrhage from groin wounds proved fatal in two dogs within a few days of commencing Arvin therapy. Therapy was continued in the seven remaining dogs for 3 weeks, at the end of which time venography was repeated and the veins were examined histologically. None of the thrombosed veins showed restoration of vein patency during Arvin therapy (table 4) . Histologic examination showed that organization was proceeding in the thrombi of the Arvin-treated animals but lagged behind that present in the control animals at an identical stage.
Treatment of Established Thrombosis with Heparin
Large doses of heparin (I.V. 10 ,000 units every 6 hours in animals weighing about 10 kg) were not successful in preventing thrombosis. This dosage of heparin was associated with a high mortality and morbidity of the animals, and thus heparin was not used in the treatment of established thrombosis. When Arvin was administered in the presence of preformed thrombi, there was no lysis of the thrombus even though the thrombus was less than 24 hours old. This study complements the in vitro study which showed that Arvin possesses no thrombolytic activity. 6 Thus the benefit noted with Arvin therapy in clinical deep-vein thrombosis 3' iS probably not due to the lysis of the thrombus. In a more recent study, Kakkar's group2l showed that Arvin therapy (administered for at least 5 days) resulted in the resolution of the deep vein thrombus in only one of 10 patients studied. The clinical benefit may have been due to the opening of collateral pathways and to the prevention of the propagation of the thrombus. Heparin has also been shown to reduce the propagation of thrombi when given after thrombosis had occurred. '4-16 
